• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Chris Kay

Stay informed with Chris Kay’s coverage and analysis for Fortune.

  • DHAKA, BANGLADESH &#8211; 2021/10/28: Vials containing Sinopharm COVID19 vaccine seen during a vaccination campaign at a vaccination center in Dhaka.<br />
According to the Bangladesh Directorate General of Health Services (DGHS), the nationwide mass vaccination program aims at injecting 7.5 million people to mark the 75th birthday of Bangladeshi Prime Minister Sheikh Hasina. (Photo by Sazzad Hossain/SOPA Images/LightRocket via Getty Images)Health

    A Sinopharm booster generates ‘significantly lower’ levels of antibodies against Omicron, according to a new study

    By Chris Kay and Bloomberg
  • Florists sell marigold garlands from the back of their trucks at a wholesale flower market set up daily along a highway during Diwali in Ghazipur, Uttar Pradesh, India, on Thursday, Nov. 4, 2021. India&#8217;s rising pace of vaccinations against Covid-19 and an improvement in the labor market is boosting consumer demand in the holiday season. Photographer: Anindit Mukherjee/Bloomberg via Getty ImagesInternational

    India drops COVID travel restrictions for vaccinated tourists from 99 countries after 20 months

    By Chris Kay and Bloomberg
  • NEW DELHI, INDIA &#8211; OCTOBER 21: A health worker draws a dose of the Covaxin vaccine into a syringe during a vaccination against the Covid-19 coronavirus at a health centre, as India celebrate 1 billion doses of COVID-19 vaccination, in New Delhi India, October 21, 2021. (Photo by Amarjeet Kumar Singh/Anadolu Agency via Getty Images)International

    WHO grants emergency authorization to India’s COVID-19 vaccine Covaxin

    By Chris Kay, Corinne Gretler, and others
  • Aerial view of the graves of COVID-19 victims at the Nossa Senhora Aparecida cemetery in Manaus, Amazon state, Brazil, on April 15, 2021. &#8211; Covid-19 has claimed more than 3,000 lives per day on average in Brazil over the past week, the most by far worldwide. The country of 212 million people has a total death toll of more than 360,000, second only to the United States. (Photo by Michael DANTAS / AFP) (Photo by MICHAEL DANTAS/AFP via Getty Images)Health

    COVID is deadlier in Brazil—and nobody knows why

    By Chris Kay, Andre Romani Pinto, and others
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.